Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 250 participants.
Also called NCT04687111
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 250 participants
- Sponsor
- Mark Ledwidge
- Registry
-
NCT04687111 -
2015-002928-53
-
- Other papers using this trial's data
- Cine-derived mitral annular relaxation velocity for detection of preclinical left ventricular diastolic dysfunction
- Effect of Sacubitril/Valsartan vs Valsartan on Left Atrial Volume in Patients With Pre-Heart Failure With Preserved Ejection Fraction: The PARABLE Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Ireland
- Registry status
- Unknown status
Technical summary
Registry record NCT04687111. Randomized; quadruple masking; primary purpose prevention. Start 2015-12-16 (actual); primary completion 2021-06-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation
- Acronym
- PARABLE
- Condition
- Atrial Remodeling
- Condition
- Myocardial Dysfunction
- Condition
- Left Ventricular Remodeling
- Condition
- Left Ventricular Diastolic Dysfunction
- Condition
- Hypertension
- Condition
- Cardiovascular Morbidity
- Condition
- Fibrosis Myocardial
- Condition
- Inflammatory Myopathy
- Condition
- Atrial Arrhythmia
- Intervention (Drug)
- Sacubitril-Valsartan
- Intervention (Drug)
- Valsartan
- Lead sponsor
- Mark Ledwidge
- Collaborator
- The Heartbeat Trust
Record details
- Record id
cardio:ct-nct04687111- Content hash
fc78a278be92451690eec7183e645185349b4e9cb00f7a79a1ce42b150ebb7cb